Altria Requests FTC to Drop Juul Acquisition Lawsuit

Mar.08.2023
Altria Requests FTC to Drop Juul Acquisition Lawsuit
Altria asks FTC to drop lawsuit over Juul acquisition, citing recent termination of investment and non-compete agreement.

According to a report from Reuters, Altria is asking the US Federal Trade Commission to drop its charges against the company's purchase of 35% of Juul in 2018. On March 3rd, the tobacco giant announced that it had exchanged its shares for Juul's heated tobacco intellectual property patents.


The Federal Trade Commission believes that Altria's $12.8 billion investment in Juul violates antitrust laws, as the company gained market position through an acquisition rather than continuing competition with Juul in the closed e-cigarette market.


In February 2022, an administrative judge dismissed charges by the Federal Trade Commission, stating that the evidence did not support the alleged violation. The next step is for the entire Commission to decide whether to accept the ruling and dismiss the case brought by the FTC.


However, Altria recently pulled out its investment in Juul and terminated a non-compete agreement with Juul that had previously been opposed by the Federal Trade Commission.


The transaction no longer has any parts that require accusation, as it has become meaningless," wrote Altria Group and Juul in documents submitted to the Federal Trade Commission.


Reference:


Altria has requested the Federal Trade Commission to dismiss the lawsuit regarding its acquisition of Juul.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

US FDA Rejects Imperial Tobacco’s blu 2.4% E-Cigarette Application, Citing Failure to Prove Health Benefits Outweigh Risks
US FDA Rejects Imperial Tobacco’s blu 2.4% E-Cigarette Application, Citing Failure to Prove Health Benefits Outweigh Risks
The US Food and Drug Administration (FDA) has issued a Marketing Denial Order (MDO) for Imperial Tobacco’s blu® Disposable Classic Tobacco 2.4% e-cigarette, prohibiting its sale and distribution in the United States. FDA’s review found that the company’s Premarket Tobacco Product Application (PMTA) did not provide sufficient evidence to demonstrate that the product could help smokers fully switch to e-cigarettes or significantly reduce cigarette consumption. Instead, existing evidence suggested
Aug.20 by 2FIRSTS.ai
Australia Cracks Down on Illegal Vapes: Melbourne Retail Store Caught with $30,000 Worth of Goods
Australia Cracks Down on Illegal Vapes: Melbourne Retail Store Caught with $30,000 Worth of Goods
Australian authorities have intensified efforts against the illegal vape trade, with the Therapeutic Goods Administration (TGA) and Victoria Police seizing around AUD 40,000 (USD 30,000) worth of illegal e-cigarettes from a well-known retail store in central Melbourne. Additional illegal tobacco and cash were also discovered on-site
Aug.18 by 2FIRSTS.ai
JTI Korea Launches Ploom Payback Promotion: Full Refund for Ploom X Advanced if Unsatisfied
JTI Korea Launches Ploom Payback Promotion: Full Refund for Ploom X Advanced if Unsatisfied
JTI Korea introduces "Ploom Payback" promotion, offering full refunds for unsatisfied buyers of Ploom X Advanced devices.
Sep.02 by 2FIRSTS.ai
Company | Philip Morris CEO: Expected profit growth in 2025 will be the highest in over a decade, with ZYN US retail sales up 32%
Company | Philip Morris CEO: Expected profit growth in 2025 will be the highest in over a decade, with ZYN US retail sales up 32%
At the 2025 Barclays Global Consumer Conference, Philip Morris International's CEO said that strong summer sales of IQOS and ZYN will boost the company's full-year 2025 adjusted EPS by 13% to 15%, the best performance since 2011 (excluding pandemic recovery). He also noted that IQOS has maintained strong growth in Q3, with ZYN sales up about 32% in the first eight weeks. The full-year shipment volume is expected to be between 800 million and 840 million cans.
Sep.03 by 2FIRSTS.ai
2Firsts Interview with IBVTA: UK Vape Tax May Weaken Harm Reduction Efforts
2Firsts Interview with IBVTA: UK Vape Tax May Weaken Harm Reduction Efforts
As the UK prepares to introduce its first-ever vape tax in 2026, questions are growing about how the measure will reshape the country’s harm reduction landscape. IBVTA tells 2Firsts that while it was not in favour of the new duty, it accepts that it is being implemented and is working with regulators to ensure a smooth rollout — warning, however, that higher costs could slow smokers’ transition to safer alternatives.
Oct.07
Exclusive 2Firsts Contribution | Dr. Ziauddin Islam: Smoke-Free Pakistan — Dream or Reality?
Exclusive 2Firsts Contribution | Dr. Ziauddin Islam: Smoke-Free Pakistan — Dream or Reality?
This article, contributed by Dr. Ziauddin Islam, public health professional and former Focal Person of Pakistan to the WHO FCTC, reflects on Sweden’s achievement as the first “smoke free” nation. He argues Pakistan can learn from Sweden’s strict policies and harm reduction strategy, urging stronger enforcement, public awareness, and adoption of reduced-risk products to move toward a smoke free future.
Sep.01